Loading
NASDAQHealthcareMedical - Devices
Latest quote
$0.8298
+$0.1171 · +16.43%
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
Previous close
$0.8298
+$0.1171 · +16.43%
Regular session · ET · Market data may be delayed.
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
Day range
Current $0.8298
52-week range
Current $0.8298
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
55
Fair Value
Sentiment
50
Mixed
Risk
71
High Risk
Momentum
17
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
Day range
Current $0.8298
52-week range
Current $0.8298
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 13.02M USD | 11.28M USD | 9.91M USD | 8.58M USD | 1.3M USD |
| Cost of goods sold | 25.81M USD | 21.89M USD | 16.5M USD | 15.46M USD | 2.82M USD |
| Gross profit | −12.79M USD | −10.61M USD | −6.59M USD | −6.88M USD | −1.51M USD |
| Research and development | 19.24M USD | 20.18M USD | 26.05M USD | 26.51M USD | 17.12M USD |
| Selling, general, and administrative | 27.1M USD | 25.75M USD | 28.39M USD | 45.63M USD | 41.74M USD |
| Operating expenses | 47.91M USD | 46.14M USD | 56M USD | 72.33M USD | 60.05M USD |
| Interest income | 1.42M USD | 2.87M USD | 1.65M USD | 789K USD | — |
| Interest expense | — | — | — | — | 288K USD |
| Depreciation and amortization | 11.7M USD | 11.73M USD | 11.81M USD | 11.51M USD | 2.29M USD |
| Operating income | −60.7M USD | −56.75M USD | −62.59M USD | −109.71M USD | −61.56M USD |
| Net income | −75.02M USD | −53.52M USD | −60.78M USD | −105.24M USD | −61.8M USD |
Company facts updated Sep 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$3.00
261.53% upsideFunds reporting this stock among their holdings, ordered by reported position size.
iShares Micro-Cap ETFIWC
State Street SPDR Portfolio Developed World ex-US ETFSPDW
State Street SPDR S&P International Small Cap ETFGWXAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
